Bye-bye Pfizer: The issues brought up by this bid remain unresolved

There is little reason to think that Pfizer will not be back after the six-month cooling off period comes to an end

Share

Few will weep as Pfizer departs our shores. The American giant sailed into Britain far too heavy-handedly, failing to pay adequate attention to those with an interest in AstraZeneca’s future – be that the science community, the company and its shareholders, or Westminster.

That Pfizer should have been so remiss, given the repeated backlashes against it in previous job-and research-cutting takeovers, was one of the most remarkable aspects of this tax-driven merger attempt. Despite all its talk of investment and speeding drugs to market, in Pfizer’s eyes this was always a transaction motivated largely by a desire to avoid US taxes, and take advantage of Britain’s rising status as an offshore haven.

That desire is not going to go away. Indeed, the appetite of American companies to do similar tax-motivated deals for British companies will only increase in the coming months as Washington moves to close off the loophole that allows them.

Other deals – such as a mooted US bid for InterContinental Hotels - are already coming, and there is little reason to think that Pfizer will not be back after the six-month cooling off period comes to an end.

So while the immediate storm may have passed, there must now be a serious debate, and quickly, about which of our industries we want to protect from foreign takeover in the public interest, and which we are happy to let go. We should also consider a halfway house, whereby certain industries are protected by an independent body to adjudicate on overseas takeovers.

Pfizer’s bid approach may have run out of time, but there are lessons from it to be heeded, and urgently.

React Now

Latest stories from i100
iJobs Job Widget
iJobs General

Reach Volunteering: Financial Trustee and Company Secretary

Voluntary Only - Expenses Reimbursed: Reach Volunteering: A trustee (company d...

Recruitment Genius: Senior Project Manager

£45000 - £65000 per annum: Recruitment Genius: This is a fantastic opportunity...

Recruitment Genius: Shopfitter

Negotiable: Recruitment Genius: This is an opportunity to join a successful an...

Recruitment Genius: Digital Sales Account Manager

£25000 - £30000 per annum: Recruitment Genius: A Digital Sales Account Manager...

Day In a Page

Read Next
 

Note to footballers: doing the right thing is more than a PR job

Simon Barnes
 

The royal dress code can't cloak Prince Charles

Joan Smith
Mau Mau uprising: Kenyans still waiting for justice join class action over Britain's role in the emergency

Kenyans still waiting for justice over Mau Mau uprising

Thousands join class action over Britain's role in the emergency
Isis in Iraq: The trauma of the last six months has overwhelmed the remaining Christians in the country

The last Christians in Iraq

After 2,000 years, a community will try anything – including pretending to convert to Islam – to avoid losing everything, says Patrick Cockburn
Black Friday: Helpful discounts for Christmas shoppers, or cynical marketing by desperate retailers?

Helpful discounts for Christmas shoppers, or cynical marketing by desperate retailers?

Britain braced for Black Friday
Bill Cosby's persona goes from America's dad to date-rape drugs

From America's dad to date-rape drugs

Stories of Bill Cosby's alleged sexual assaults may have circulated widely in Hollywood, but they came as a shock to fans, says Rupert Cornwell
Clare Balding: 'Women's sport is kicking off at last'

Clare Balding: 'Women's sport is kicking off at last'

As fans flock to see England women's Wembley debut against Germany, the TV presenter on an exciting 'sea change'
Oh come, all ye multi-faithful: The Christmas jumper is in fashion, but should you wear your religion on your sleeve?

Oh come, all ye multi-faithful

The Christmas jumper is in fashion, but should you wear your religion on your sleeve?
Dr Charles Heatley: The GP off to do battle in the war against Ebola

The GP off to do battle in the war against Ebola

Dr Charles Heatley on joining the NHS volunteers' team bound for Sierra Leone
Flogging vlogging: First video bloggers conquered YouTube. Now they want us to buy their books

Flogging vlogging

First video bloggers conquered YouTube. Now they want us to buy their books
Saturday Night Live vs The Daily Show: US channels wage comedy star wars

Saturday Night Live vs The Daily Show

US channels wage comedy star wars
When is a wine made in Piedmont not a Piemonte wine? When EU rules make Italian vineyards invisible

When is a wine made in Piedmont not a Piemonte wine?

When EU rules make Italian vineyards invisible
Look what's mushrooming now! Meat-free recipes and food scandals help one growing sector

Look what's mushrooming now!

Meat-free recipes and food scandals help one growing sector
Neil Findlay is more a pink shrimp than a red firebrand

More a pink shrimp than a red firebrand

The vilification of the potential Scottish Labour leader Neil Findlay shows how one-note politics is today, says DJ Taylor
Bill Granger recipes: Tenderstem broccoli omelette; Fried eggs with Mexican-style tomato and chilli sauce; Pan-fried cavolo nero with soft-boiled egg

Oeuf quake

Bill Granger's cracking egg recipes
Terry Venables: Wayne Rooney is roaring again and the world knows that England are back

Terry Venables column

Wayne Rooney is roaring again and the world knows that England are back
Michael Calvin: Abject leadership is allowing football’s age-old sores to fester

Abject leadership is allowing football’s age-old sores to fester

Those at the top are allowing the same issues to go unchallenged, says Michael Calvin